US/UK/Canada

Share

Pick a time period -
Tags ( Active)

Capio continues building its digi-physical healthcare offering in Sweden

Capio has signed an agreement to acquire the primary care center Tibra Medica with operations in Kista in the western part of Stockholm, Sweden. The unit adds 7,000 listed patients to Capio’s network of about 900,000 listed patients in Sweden. The acquisition strengthens Capio’s digi-physical network of digital healthcare services and physical consultations in the Stockholm area.The Tibra Medica primary care center is located in Kista, which is a fast-growing part of the Stockholm area. Tibra Medica fits well with Capio’s existing primary care centers in Stockholm and adds to Capio’s

Ramsay Générale de Santé and Capio announce new executive committee for the combined Group

Since 7 November 2018, Ramsay Générale de Santé and Capio have formed a single Group. Having the same ambition of medical excellence, the same way of continuously improving quality of care, yet driven by different backgrounds, we will now build a common future, for the benefit of all.“Over the last two months, the numerous meetings I have had in each country have convinced me that our different teams share the same ambition of medical excellence, the same way of continuously improving quality of care, yet driven by different backgrounds. Our size, the diversity and complementarity of our

New Board of Directors of Capio AB (publ) and change in executive responsibility

At the extraordinary general meeting in Capio AB (publ) held today in Gothenburg, Sweden, a new board was elected. The board as from today consists of the following members (all newly elected):Pascal Roché (chairman of the board), CEO of Ramsay Générale de SantéArnaud Jeudy, CFO of Ramsay Générale de SantéDamien Michon, COO of Ramsay Générale de SantéBritta Wallgren, Country President Capio in SwedenHenrik Brehmer, SVP Group Communications & Public Affairs of CapioThe unions’ elected employee representatives, Kevin Thompson and Bengt Sparrelid, are remaining as members of the

Capio AB (publ) applies for de-listing

Following that Ramsay Générale de Santé controls approximately 98.5 per cent of the shares in Capio and has initiated compulsory redemption proceedings regarding the remaining shares in the Company, the Board of Capio has, after a proposal from Ramsay GdS, resolved to apply for de-listing of the Company’s shares from Nasdaq Stockholm. Ramsay Générale de Santé S.A. (“Ramsay GdS”) declared the public offer for Capio AB (publ) (“Capio” or the “Company”) unconditional on 26 October 2018. As further announced by Ramsay GdS on 8 November 2018, Ramsay GdS controls approximately 98.5 per cent of

Extraordinary general meeting in Capio AB (publ)

At the request of Ramsay Générale de Santé S.A. (“Ramsay GdS”), which after completion of its public cash offer to the shareholders of Capio AB (publ) (“Capio”) holds approximately 98.5 percent of the total number of shares and votes in Capio, the shareholders of Capio are given notice of the Extraordinary General Meeting (EGM) to be held at Mannheimer Swartling Advokatbyrå, Östra Hamngatan 16, 403 14 Gothenburg, Sweden, at 9:00 a.m. CET on Tuesday, 4 December 2018. Registration will commence from 8:30 a.m. CET.A. RIGHT TO PARTICIPATE IN THE EXTRAORDINARY GENERAL MEETING Shareholders who

Capio awarded an extension of the contract to run Capio S:t Göran’s hospital and two acute geriatric contracts in Stockholm

The Stockholm County Council (SCC) has resolved to extend Capio’s contract to run Capio S:t Göran’s hospital from January 2022 to January 2026. At the same time the SCC resolved to trust Capio to continue to run the acute geriatric activities at Nacka hospital and awarded Capio a new contract to run the acute geriatric activities at Löwenströmska hospital. Annual net sales of the S:t Göran contract is approximately SEK 2 billion while the two acute geriatric contracts have combined annual net sales of approximately MSEK 250.Capio has successfully been running hospital care at S:t Göran’s

Capio appoints Marcus Nord as new CFO for the Capio Group

Marcus Nord has been appointed new Chief Financial Officer (CFO) for the Capio Group, replacing Olof Bengtsson who has decided to leave Capio after 9 years with the company. Marcus Nord enter upon his new position on December 1, 2018.Marcus Nord joined Capio in 2005 and is today deputy CFO of the Capio Group. Prior to that, Marcus has held several management positions within the Group Finance function, including SVP Group Control and Reporting in Capio.Olof Bengtsson has been CFO since 2013 and was prior to that Chief Corporate Finance and Group Treasury in Capio. For information,

Capio AB (publ) Interim report January – September 2018

July - September 2018 · Net sales MSEK 3,816 (3,455). Organic sales growth 2.1% (2.2) and total sales growth 10.4% (9.1) · EBITDA[1] MSEK 189 (168) and margin 5.0% (4.9). EBITDA increased by 12.5% · EBITA[1] MSEK 66 (53) and margin 1.7% (1.5). EBITA increased by 24.5% · Operating result (EBIT) MSEK -39 (18) and margin -1.0% (0.5). EBIT decreased by 316.7% · Profit for the period[2] MSEK -54 (-7). Earnings per share after dilution[2] SEK -0.36 (-0.03) January - September 2018 · Net sales MSEK 12,151 (11,250). Organic sales growth 1.6% (2.0) and total sales

Capio to publish Interim report on October 30, 2018

Capio AB will publish the Interim report for January-September 2018 on Tuesday, October 30 at approximately 08.00 am (CET).08.00 am (approximately) Report release. The report will be sent as a press release and will be published on Capio’s website www.capio.com. In light of the ongoing public takeover offer from Ramsay Générale de Santé, Capio announced preliminary quarterly results for the period July-September 2018 on October 11, 2018. For further information, please refer to the press release 

Capio publishes preliminary quarterly results for the period July-September 2018

In light of the ongoing public takeover offer from Ramsay Générale de Santé, Capio announces preliminary quarterly results for the period July-September 2018 ahead of the preannounced date for the publication of the interim report on October 30, 2018.Preliminary quarterly results for the Capio Group: ·  Continued strong development in the Nordics while France is improving in a weak market and Germany under restructuring according to plan ·  Investments in digitalization of healthcare impacted the Nordic segment by MSEK -12 (-2) in the quarter · Net sales MSEK 3,816 (3,455).

The Board of Capio unanimously recommends shareholders of Capio to accept the increased cash offer from Ramsay GdS and cancels the announced EGM

Following the cash offer from Ramsay Générale de Santé (“Ramsay GdS”) on July 13, 2018, of SEK 48.50 per share (the “Initial Offer”), Ramsay GdS announced an increased cash offer of SEK 58 per share (the “Increased Offer”) to the shareholders in Capio on October 8, 2018. The Increased Offer represents a premium of approximately 39 per cent to the closing price of SEK 41.80 per share on Nasdaq Stockholm on July 12, 2018 (the last trading day prior to the announcement of the Initial Offer), a premium of approximately 14% to the closing price of SEK 50.80 per share on Nasdaq Stockholm on October

The Board of Directors of Capio evaluates the increased public cash offer from Ramsay Génerale de Santé

Following the unsolicited cash offer from Ramsay Génerale de Santé (Ramsay GDS) on July 13 of SEK 48.50 per share, unanimously rejected by the Board of Directors of Capio on the same day, Ramsay GDS has today announced an increased cash offer of SEK 58.00 per share (the “Increased Offer”) to the shareholders in Capio representing a premium of approximately 14% to the closing price of SEK 50.80 per share on Nasdaq Stockholm on October 5, 2018, and a premium of approximately 20% to the initial offer by Ramsay GDS of SEK 48.50 per share on July 13, 2018. The Board of Directors of Capio will

Extraordinary general meeting in Capio AB (publ)

The shareholders of Capio AB are hereby invited to attend the Extraordinary General Meeting (the “Meeting”) for the primary purpose of resolving on an approval of the proposed sale of Capio Santé SA. The Meeting will be held at Mannheimer Swartling Advokatbyrå, Östra Hamngatan 16, 403 14 Gothenburg, at 4:00 p.m. CEST on Thursday 18 October 2018. Registration will commence from 3:30 p.m. CEST.A. RIGHT TO PARTICIPATE IN THE EXTRAORDINARY GENERAL MEETING Shareholders who wish to participate in the Meeting must: firstly, be registered in the share register maintained by Euroclear Sweden

Capio announces notice of Extraordinary General Meeting and information on the use of proceeds from the proposed sale of Capio France

Capio today announces the notice of the Extraordinary General Meeting (the “EGM”) convened to resolve on the Board’s proposal to approve the sale of Capio France. The EGM will be held at 4.00 p.m. CEST on 18 October 2018. Capio also announces information on the use of proceeds from the sale of Capio France, should the EGM approve the transaction.The proceeds from the transaction will be used partly to pay down Capio Group debt and partly as a return of cash to shareholders. The return of cash to shareholders is expected to be between BSEK 1.8-2.1, equating to SEK 13-15 on a current per

Capio closes acquisition of the Swedish healthcare group Legevisitten

The acquisition of Legevisitten, announced on July 11, 2018, has now been approved by the relevant county councils and the Swedish Competition Authority. Following the approvals, Capio closes the acquisition as of today, and includes Legevisitten in Capio Group as from September 1, 2018.The acquisition increases Capio’s capacity within geriatrics and related services for the elderly in the Stockholm area and strengthens Capio’s position facing the geriatric free healthcare choice introduction in Stockholm in 2019. The acquisition also adds about 82,000 listed patients to Capio’s base of

Capio announces the proposed sale of Capio France to Vivalto Santé

Capio and Vivalto Santé (“Vivalto”) today announce that they have entered into exclusivity regarding the proposed sale of Capio France to Vivalto pending the finalization of the documentation related thereto as is customary in the French market. The consideration for the proposed transaction would be an upfront enterprise value of MEUR 425 plus an earn-out contingent on 2018 financial performance, up to a total enterprise value of MEUR 455. The proposed purchase by Vivalto is binding on Vivalto and fully financed. The proposed transaction would accelerate the positioning towards the less

Capio AB (publ) Interim report January – June 2018

April - June 2018 ·  Net sales MSEK 4,179 (3,881). Organic sales growth 1.6% (0.5) and total sales growth 7.7% (8.6) ·  EBITDA¹ MSEK 262 (256) and margin 6.3% (6.6). EBITDA increased by 2.3% ·  EBITA¹ MSEK 138 (142) and margin 3.3% (3.7). EBITA decreased by 2.8%   ·  Operating result (EBIT) MSEK 123 (108) and margin 2.9% (2.8). EBIT increased by 13.9% ·  Profit for the period² MSEK 75 (70). Earnings per share after dilution² SEK 0.53 (0.50) January - June 2018 ·  Net sales MSEK 8,335 (7,795). Organic sales growth 1.4% (1.9) and total sales growth 6.9% (8.6) ·

The Board of Directors of Capio rejects the public cash offer from Ramsay Genérale de Santé

Following the public cash offer from Ramsay Génerale de Santé (Ramsay GDS) on July 13, the Board of Directors of Capio has unanimously decided to reject the Offer of SEK 48.50 per share, representing a premium of approximately 16 per cent to the closing price of SEK 41.80 per share on Nasdaq Stockholm on 12 July 2018. The Board believes the Offer does not adequately reflect the fundamental value of Capio and believes that a possible repositioning of Capio towards the Nordic markets has the potential to significantly enhance the ability to deliver Capio’s strategic focus and drive shareholder

Capio acquires the Swedish healthcare group Legevisitten

Capio has signed an agreement to acquire 100% of Legevisitten with specialist care operations, mainly focusing on healthcare for the elderly, and primary care activities. In 2017, the group’s net sales were MSEK 613, of which 90% was related to free healthcare choice and 10% to tendered contracts. The acquisition increases Capio’s capacity within geriatrics and related services for the elderly in the Stockholm area and strengthens Capio’s position facing the geriatric free healthcare choice introduction in Stockholm in 2019.“We are very pleased with the opportunity to acquire Legevisitten

Capio to publish Interim report on July 20, 2018

Capio AB will publish the Interim report for January-June 2018 on Friday, July 20 at approximately 08.00 am (CET).08.00 am (approximately)Report release. The report will be sent as a press release and will be published on Capio’s website www.capio.com. 09.30 am Telephone conference and audio castInvestors, analysts and media are invited to participate in a telephone conference at 09.30 am (CET).President and CEO Thomas Berglund and CFO Olof Bengtsson will present the report and answer questions (in English). The telephone conference will be audio casted live on www.capio.com.

Capio confirms talks about possible structural changes

In response to market rumours, Capio confirms ongoing discussions relating to possible divestments of its non-Nordic operations.Capio continuously evaluates different alternatives to drive growth and create shareholder value. As part of assessing several alternatives, Capio has been approached by potential buyers and has engaged in discussions concerning its non-Nordic operations. With Capio’s strong base in Modern Medicine and strategic direction towards specialization and digitalization, the board of directors of Capio sees it logical to evaluate these approaches in order to assess

Capio appoints Attila Vegh as new CEO

The Board of Directors of Capio AB has today appointed Attila Vegh as the new President and CEO for Capio AB. He is currently CEO of Penta Hospitals International, the leading hospital chain in Central and Eastern Europe. Attila Vegh will replace Thomas Berglund within a 6 month period. Thomas will stay in position until the new CEO takes office."I am pleased to announce the appointment of Attila Vegh as the new CEO for Capio. He will bring a wide range of experience combined with a dedication to manage change and transformation in clinical environments, both in the private and the public

There are no items matching the current filter
There are no more items matching the current filter
Back to top

Media